Brain HealthOverlooked P3 peptide may be a hidden driver of Alzheimer's disease
Alzheimer's research has spent decades and billions of dollars targeting amyloid beta, with disappointing results. A new commentary in ChemBioChem from UC Santa Cruz biochemist Jevgenij Raskatov points to another suspect: a smaller, closely related peptide called P3. Once considered harmless, P3 appears able to form clumps and threadlike fibrils, apparently even faster than amyloid beta. Evidence also suggests P3 may interact with amyloid beta, possibly changing how it builds up and how toxic it becomes. Together, these findings raise the possibility that P3 contributes to the nerve cell damage seen in Alzheimer's. Raskatov says P3 is probably not an innocent bystander, though more research is needed. If P3 proves important, it could reshape how scientists design Alzheimer's prevention strategies and drugs. The work is a commentary highlighting existing research, not a new clinical trial, so it points to a promising direction rather than a proven treatment target.
